SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 423.23 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 58.75 |
| Book Value / Share | 1.53 |
| Price / Book | n/a |
| NCAV ($M) | 18.96 |
| NCAV / Share | 0.49 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.07 |
| Return on Assets (ROA) | -0.06 |
| Return on Equity (ROE) | -0.07 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.69 |
| Current Ratio | 2.14 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 44.75 |
| Assets | 84.54 |
| Liabilities | 25.79 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 75.56 |
| Operating Income | 0.11 |
| Net Income | -4.29 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 3.14 |
| Cash from Investing | -1.11 |
| Cash from Financing | 1.34 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| CNBX – CNBX Pharmaceuticals Inc. | CPMD – CannaPharmaRX, Inc. |
| CPMV – Mosaic ImmunoEngineering, Inc. | CUBT – Curative Biotechnology, Inc. |
| CURLF – Curaleaf Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io